A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).Peijing Li, Yuan Yuan Yuan Chen,Shuzhen Lai,Fagui Jiang,Xiaohui Liu,Changjuan Tao,Lei Wang,Guihong Liu,Jing Huang,Yiqiang Tang,Zhigang Liu,Guoping Shen,Chaoming Li,Tieming Xie,Fangxiao LuJOURNAL OF CLINICAL ONCOLOGY(2021)引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要